Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
151
-
Total 13F shares, excl. options
-
77.2M
-
Shares change
-
+2.59M
-
Total reported value, excl. options
-
$950M
-
Value change
-
-$27.8M
-
Put/Call ratio
-
0.53
-
Number of buys
-
97
-
Number of sells
-
-70
-
Price
-
$12.30
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q4 2017
204 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q4 2017.
Evolent Health, Inc. - Class A Common Stock (EVH) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.2M shares
of 112M outstanding shares and own 69.19% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (7.89M shares), JPMORGAN CHASE & CO (7.47M shares), Vanguard Group Inc (5.02M shares), BlackRock Inc. (3.76M shares), Bank of New York Mellon Corp (3.44M shares), BLAIR WILLIAM & CO/IL (2.97M shares), MILLENNIUM MANAGEMENT LLC (2.82M shares), RIVERBRIDGE PARTNERS LLC (2.68M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2.27M shares), and FORMULA GROWTH LTD (2.04M shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.